Zomax was a brand of zomepirac sold by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, from 1980 to 1983. The drug was withdrawn and discontinued in March 1983 due to its tendency to cause serious anaphylaxis in patients.
1980–1983[]
|
SVG NEEDED |
_(1).png "Zomax 1980 (Alt) (1).png (344 KB)")
Alternate variant 
_(2).png "Zomax 1980 (Alt) (2).png (295 KB)")
Alternate variant
_(3).png "Zomax 1980 (Alt) (3).png (254 KB)")
Alternate variant
_(4).png "Zomax 1980 (Alt) (4).png (333 KB)")
Alternate variant 
| J&J Innovative Medicine Subsidiaries: Actelion | ALZA Corporation | Cilag | Crucell | J&J Pharmaceutical Research and Development | Ortho-McNeil Pharmaceutical | Tibotec J&J MedTech Former assets: 1Johnson & Johnson retained 9.5% shares in Kenvue, its former consumer health unit.  |